BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30586215)

  • 1. Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep.
    Gobbi G; Comai S
    J Pineal Res; 2019 Apr; 66(3):e12544. PubMed ID: 30586215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin promotes sleep in mice by inhibiting orexin neurons in the perifornical lateral hypothalamus.
    Sharma R; Sahota P; Thakkar MM
    J Pineal Res; 2018 Sep; 65(2):e12498. PubMed ID: 29654707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Function of Melatonin MT
    Gobbi G; Comai S
    Front Endocrinol (Lausanne); 2019; 10():87. PubMed ID: 30881340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout mice.
    Comai S; Ochoa-Sanchez R; Gobbi G
    Behav Brain Res; 2013 Apr; 243():231-8. PubMed ID: 23333399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
    Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
    J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
    Imbesi M; Uz T; Manev H
    Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states.
    Ochoa-Sanchez R; Comai S; Spadoni G; Bedini A; Tarzia G; Gobbi G
    Neurosci Lett; 2014 Feb; 561():156-61. PubMed ID: 24406151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors.
    Sumaya IC; Masana MI; Dubocovich ML
    J Pineal Res; 2005 Sep; 39(2):170-7. PubMed ID: 16098095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of melatonin membrane receptors in melatonin-dependent oxytocin secretion from the rat hypothalamo-neurohypophysial system - an in vitro and in vivo approach.
    Juszczak M; Wolak M; Bojanowska E; Piera L; Roszczyk M
    Endokrynol Pol; 2016; 67(5):507-514. PubMed ID: 26884304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptive responses in melatonin MT
    Posa L; Lopez-Canul M; Rullo L; De Gregorio D; Dominguez-Lopez S; Kaba Aboud M; Caputi FF; Candeletti S; Romualdi P; Gobbi G
    J Pineal Res; 2020 Oct; 69(3):e12671. PubMed ID: 32430930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity.
    Barberino RS; Menezes VG; Ribeiro AEAS; Palheta RC; Jiang X; Smitz JEJ; Matos MHT
    Biol Reprod; 2017 Jun; 96(6):1244-1255. PubMed ID: 28595266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
    Zlotos DP; Jockers R; Cecon E; Rivara S; Witt-Enderby PA
    J Med Chem; 2014 Apr; 57(8):3161-85. PubMed ID: 24228714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors.
    Imbesi M; Uz T; Dzitoyeva S; Giusti P; Manev H
    Brain Res; 2008 Aug; 1227():19-25. PubMed ID: 18621029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MT1 and MT2 melatonin receptors are expressed in nonoverlapping neuronal populations.
    Klosen P; Lapmanee S; Schuster C; Guardiola B; Hicks D; Pevet P; Felder-Schmittbuhl MP
    J Pineal Res; 2019 Aug; 67(1):e12575. PubMed ID: 30937953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
    Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
    J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
    Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sites and mechanisms of action of melatonin in mammals: the MT1 and MT2 receptors].
    Schuster C
    J Soc Biol; 2007; 201(1):85-96. PubMed ID: 17762828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat.
    Fisher SP; Sugden D
    Neurosci Lett; 2009 Jun; 457(2):93-6. PubMed ID: 19429170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.
    Liu J; Clough SJ; Hutchinson AJ; Adamah-Biassi EB; Popovska-Gorevski M; Dubocovich ML
    Annu Rev Pharmacol Toxicol; 2016; 56():361-83. PubMed ID: 26514204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.